Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000798
UniProt IDP23743
Primary gene name(s)DGKA
Synonym gene name(s)DAGK, DAGK1
Protein nameDiacylglycerol kinase alpha
Protein functionUpon cell stimulation converts the second messenger diacylglycerol into phosphatidate, initiating the resynthesis of phosphatidylinositols and attenuating protein kinase C activity.
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P23743
Gene Ontology
(Biological Process)
Complete annatation
diacylglycerol metabolic process [GO:0046339];
glycerolipid metabolic process [GO:0046486];
intracellular signal transduction [GO:0035556];
lipid phosphorylation [GO:0046834];
phosphatidic acid biosynthetic process [GO:0006654];
platelet activation [GO:0030168];
protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]
Gene Ontology
(Molecular Function)
Complete annatation
ATP binding [GO:0005524];
calcium ion binding [GO:0005509];
diacylglycerol kinase activity [GO:0004143];
phospholipid binding [GO:0005543]
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829];
membrane [GO:0016020];
plasma membrane [GO:0005886]
Protein-protein interaction107976
Phylogenetic treeP23743
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-1.255794745884370.0001568628785986180.000718394805906525
AZA vs. DISU-0.1957129695450230.4380731693846430.91814655876178
AZA vs. IL7-0.002026984910399850.9915593740054190.999311006273513
AZA vs. SAHA-0.2259504182142750.3535904505281570.723794466493949
DISU vs. CD31.046789328454190.004246415297865180.0141553436974834
DISU vs. IL70.1848872544643720.4621091182685880.802985910329535
DISU vs. SAHA-0.0285000899670990.9219761753664710.98235467118717
DMSO vs. AZA0.1045750468513860.5305860376014421
DMSO vs. CD31.346908461135163.43911240489048e-050.000173743220589118
DMSO vs. DISU0.2980177973408660.2211044129195380.733159745634375
DMSO vs. IL7-0.09906620827569790.5803452964058460.906883522682505
DMSO vs. SAHA-0.3365581905623510.1530335895209560.471843131683781
HIV vs. Mock in Activation-0.1499824278304610.8093120233889210.999983755607037
HIV vs. Mock in Latency-0.1296680327219410.4300683765508940.999834320637052
IL7 vs. CD31.261417705876010.0001110092843962240.000637183146879012
SAHA vs. CD31.005075772474090.004769758950330720.0137254663703425
SAHA vs. IL7-0.2278234819053370.3492948755098660.599117096183079
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
-1.1 0.322912295 -1.3 0.023910064 -1.9 0.002318356
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.372599 0.00551063
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.996 1.121 1.309 1.498 1.683
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
211272_s_at 1.41 No downregulated in CD8+ cells

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB00163 Vitamin E approved, nutraceutical, vet_approved unknown unknown

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1TUZ NMR - A=1-116.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00561 Glycerolipid metabolism - Homo sapiens (human)
hsa00564 Glycerophospholipid metabolism - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human)
hsa04072 Phospholipase D signaling pathway - Homo sapiens (human)
hsa05231 Choline metabolism in cancer - Homo sapiens (human)